Lacrimal Devices Market Size Worth USD 238.24 Million by 2034

According to Precedence Research, the global lacrimal devices market size is valued at USD 171.35 million in 2025, and it is projected to rise from USD 177.74 million in 2026 to nearly USD 238.24 million by 2034, with an expected CAGR of 3.73% from 2025 to 2034.

Ottawa, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The global lacrimal devices market size is expected to be worth over USD 238.24 million by 2034, increasing from USD 171.35 million in 2025, growing at a strong CAGR of 3.73% between 2025 and 2034. The market encompasses medical devices and implants designed to treat disorders of the tear drainage system, including dry eye disease and nasolacrimal duct obstructions.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/4899

Lacrimal Devices Market Key Insights:

North America dominated the lacrimal devices market with holding more than 36% of the market share in 2024.
Europe held the second-largest position in 2024.
By product, the stents segment contributed the highest market share in 2024.
By product, the incubation sets segment is expected to grow at the fastest CAGR from 2025 to 2034.
By application, the dry eye segment is expected to have lucrative growth during the forecast period.
By end-use, the hospital segment dominated the lacrimal devices market in 2024.
By end-use, the ophthalmic clinics segment is anticipated to have significant growth during the forecast period.

What is a Lacrimal Device?

Lacrimal devices, such as punctal plugs, stents, or irrigation systems, are small but important devices that would have a role to support the tear production and drainage system to achieve eye lubrication and comfort. The market is experiencing significant growth, as ophthalmic disorders are becoming more common, the awareness of eye health is becoming more widespread, and medical technologies are being developed.

An increase in the number of age-related eye disorders is also a major contributor to market growth, along with the rising number of the elderly population in the market, because the elderly are more susceptible to tear system malfunctions and other related complications. The rising healthcare spending, the governmental support of eye health, and the boom of vision issues among the younger generations are also a factor that contributes to the high growth trend of the market.

➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting

Latest Trends in the Lacrimal Devices Market

Growing demand for minimally invasive procedures
There is an increasing preference for less-invasive tear duct surgeries and treatments that offer quicker recovery and reduced complications.
Advancements in biomaterials and biocompatibility
New materials used in lacrimal devices are becoming more flexible, bioresorbable, and comfortable, improving patient outcomes and reducing the need for device removal.
Emergence of smart and connected devices
Innovative devices equipped with sensors and remote monitoring capabilities are enabling real-time data tracking and proactive clinical management.
Rising prevalence of lacrimal and ocular surface disorders
Conditions like dry eye syndrome and nasolacrimal duct obstruction are on the rise due to aging populations, environmental factors, and increased screen time.
Expansion into emerging markets
Increased healthcare infrastructure and awareness in regions like Asia-Pacific and Latin America are driving growth in these areas.
Improved regulatory and reimbursement landscape
Evolving healthcare policies are facilitating quicker approvals and better insurance coverage for lacrimal devices, encouraging innovation.

What is an Opportunity for the Lacrimal Devices Market?

A major market potential of the lacrimal devices is the increased efficacy of superior products and their growing use in therapy. With the current increase in the rate of eye disorders such as dry eye disease and nasolacrimal duct obstruction, especially in the older population, the demand for such innovative solutions is increasing at a faster pace. Also, new materials and technologies like biodegradable polymers and drug-eluting devices are becoming a new avenue in ophthalmic care. Such innovations provide enormous chances to manufacturers to differentiate products, enhance rates of adoption, and penetrate unexploited markets.

➤ Get the Full Report @ https://www.precedenceresearch.com/lacrimal-devices-market

What is the Limitation for the Lacrimal Devices Market?

Although the market has significant potential of growth potential, there are significant threats to the market because of the threat of side effects that may occur when using them. The surgeries that can cause complications with relation to lacrimal implants or stents include infection, excessive bleeding, implant displacement, abnormal tissue fusion, or inflammation due to bacterial, viral, or fungal pathogens.

In other situations, patients, too, may have scarring or post-operative damage, thus lowering the success of the treatment and adoption. Procedural failures and problems caused by drugs are an additional concern that restricts the acceptance of the solution in sensitive patient groups.

Lacrimal Devices Market Report Coverage

Report Attributes	Key Statistics
Market Size in 2025	USD 171.35 Million
Market Size in 2026	USD 177.74 Million
Market Size by 2034	USD 238.24 Million
Market Growth Rate (2025–2034)	CAGR of 3.73%
Leading Region in 2024	North America
Second-Largest Region	Europe
Fastest-Growing Region	Asia-Pacific
Leading Product Segment (2024)	Stents
Fastest-Growing Product Segment	Incubation Sets
Key Growth Application	Dry Eye
Dominant End-use (2024)	Hospitals
Fastest-Growing End-use	Ophthalmic Clinics
Base Year	2024
Forecast Period	2025–2034
Historical Data	2018–2023
Segments Covered	Product, Application, End-use, and Region
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Key Drivers	Growing prevalence of dry eye disease, aging population, rising ophthalmic surgeries
Key Challenges	High device cost, limited reimbursement in developing nations
Key Companies	Include Carl Zeiss Meditec, Kaneka, Cook Medical, BVI Medical

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/4899

Lacrimal Devices Market Regional Insights

How Big is the U.S. Lacrimal Devices Market?

The U.S. lacrimal devices market size is valued at USD 43.18 million in 2025 and is anticipated to reach nearly USD 61.31 million by 2034, with a CAGR of 3.95% from 2025 to 2034.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/4899

How North America Dominated the Lacrimal Devices Market?

North America dominated the market in 2024, which was facilitated by the increased number of eye disorders like dry eye disease and nasolacrimal duct obstruction. The area is advantageous with a good healthcare system, early usage of advanced medical technologies, and the availability of advanced ophthalmic care.

The United States, specifically, dominates the market because it has the largest investment in healthcare, it has large medical equipment manufacturing companies, and it has a good research ecology. The current technological innovations, such as biodegradable stents and drug-eluting devices, are also widely accepted in the region, indicating that the providers are ready to adopt innovation.

Why is Europe the Fastest-Growing in the Lacrimal Devices Market?

Europe experiences the fastest growth in the market during the forecast period, owing to the increasing knowledge about eye disorders and the growing avenues to advanced therapy. Germany is the most promising market in the European region because it has a large number of patients, an increasing healthcare spending, and a high rate of use of advanced medical technologies.

Moreover, firms within the region are developing well-organized direct channel alliances with ophthalmic clinics and hospitals to reach out to patients with greater effectiveness. Increasing geriatric populations in Europe, along with aggressive government programs in the area of eye health, are further propelling demand.

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Lacrimal Devices Market Segmentation Insights:

Product Insights

Why did the stents Cognitive Agents Segment Dominate the Market?

The stents segment dominated the market in 2024, because of its broad clinical usage and efficiency in preserving the tear drainage. Lacrimal stents are small tubes of metal, plastic, or fabric that are placed in the nasolacrimal system to maintain patency. They are usually applied to congenital obstructions in newborns, a decrease of complications post-surgery, infections, trauma, or malignancies, and other inflammatory diseases.

Stents help the flow of tears by ensuring the tear drainage pathway is not closed, so that the tears can flow into the nose. There are bi-canalicular and mono-canalicular types of stent. They are referred to as epipora, glaucoma, canalicular stenosis, obstruction of nasolacrimal ducts, and canalicular lacerations.

The incubation set segment is the fastest-growing in the market during the forecast period. Incubation sets are vital in surgery and diagnostics of the lacrimal system. They offer manipulated conditions and necessary assistance for handling and inserting the lacrimal apparatus, like stents. The adoption of incisionless sets is being triggered by increasing awareness about the use of minimally invasive eye procedures, technological changes in device design, and the need to have better results of the surgical procedures.

Application Insights

Which Application Segment Held the Largest Share of the Market?

The dry eye segment held the largest share in the market in 2024. Punctal plugs or other types of lacrimal devices are used to decrease excessive loss of tears down the nose and increase the duration that tears remain on the surface of the eye, thereby relieving general symptoms of burning, redness, itchiness, and dryness. Things like vision problems, corneal abrasions, ulcers, eye inflammation, and irritation are some of the complications of untreated dry eyes, which puts pressure on the need to treat it effectively.

Increased occurrences of dry eye disorders, coupled with the knowledge of sophisticated lacrimal interventions, are the two key elements that are spurring tremendous expansion in this segment.

End-Use Insights

How Hospital Segment Dominates the Market?

The hospital segment dominated the market in 2024, with its sophisticated infrastructure, equipment, and provision of advanced technology. With qualified ophthalmologists, nurses, and technicians, there is availability of a full-fledged diagnostic and treatment center for eye-related diseases in hospitals, where patients can receive adequate care and prompt treatment. The equipment to assist in the correct placement of the lacrimal devices, stents, and punctal plugs, which are essential in managing conditions like dry eye, nasolacrimal duct obstruction, and canalicular stenosis. Hospitals include better eye health outcomes, effective monitoring of patients, and affordable treatment opportunities.

The ophthalmic clinics segment is the fastest-growing in the market during the forecast period. Ophthalmic clinics are clinics that deal with eye diagnosis, treatment, and surgery all in one place. The market is experiencing growth due to the increase in awareness of eye health, the increasing rate of eye disorders, and the preference for special care of patients in clinics. Ophthalmic clinics offer easy access to highly developed care, individualized treatment plans, and effective follow-up services, which is why such clinics are appealing to patients and add significantly to the development of the lacrimal devices market.

✚ Related Topics You May Find Useful:

➡️ Stents Market: Assess how minimally invasive cardiology solutions are advancing global patient outcomes

➡️ Dry Eye Treatment Devices Market: Examine rising device-based interventions as screen fatigue and aging accelerate demand

➡️ Medical Devices Market: Track how healthcare digitization and procedural innovation are reshaping device adoption worldwide

➡️ Ophthalmic Devices Market: Identify where diagnostic and surgical technologies are transforming vision care

➡️ ENT Devices Market: Understand how chronic sinus, hearing, and airway conditions are driving advanced ENT technologies

➡️ Sleep Apnea Devices Market: Analyze the surge in demand for non-invasive respiratory support amid rising sleep disorder prevalence

➡️ Ophthalmology Market: Discover where clinical innovation is accelerating treatment for vision impairment and ocular diseases

➡️ Medical Aesthetic Devices Market: Review how non-surgical cosmetic technologies are capturing consumer-driven wellness spending

Lacrimal Devices Market Top Companies

Walsh Medical Devices Inc.
JEDMED
Braintree Scientific
Kaneka Corporation
Bess Medical Technology GmbH
Rumex International Co
Lacrimedics Inc.
BVI
Meddenium
FCI Ophthalmic
Gunther Weiss Scientific Glass

Recent Developments

In April 2025, Nordic Pharma was granted CE Mark approval on LACRIFILL to use in European markets. The milestone is beneficial to the company in its international growth as well as broader treatment access to patients with dry eye disease. Source: https://www.nordicpharma.com

In December 2023, Nordic Pharma (via its subsidiary Amring/Nordic Pharma, Inc.) purchased Visant Medical. This acquisition gave LACRIFILL canalicular gel to Nordic, which made it stronger in the market of treating eye dryness. Source: https://www.nordicpharma.com

Segments Covered in the Report

By Product

Intubation Sets
Tubes
Stents
Cannula & Spatula
Dilator
Punctal Plugs
Others

By Application

Dry Eye
Glaucoma
Epiphora
Drainage Obstruction
Lacrimal Gland Inflammation
Others

By End-use

Hospitals
Ophthalmic Clinics
Diagnostic Centers
Others

By Region

North America
Asia Pacific
Europe
Latin America
Middle East & Africa

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/4899

Stay Ahead with Precedence Research Subscriptions

Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Trusted Data Partners:

Get Recent News:

https://www.precedenceresearch.com/news

For the Latest Update Follow Us:

LinkedIn | Medium | Facebook | Twitter

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.